На главную
Результаты поиска “Generic pharmaceutical companies by state”
Planet hope - India: the generic drug war
 
11:23
Planet hope - India is the world's largest manufacturer of generic medicines. But a Supreme Court decision could upend the industry, the result of a long legal battle between a giant pharmaceutical company and advocates of generic drugs. What would the consequences be for millions of sick people around the world? Hannah Moffat brings you inspiring stories on how communities around the world are fighting poverty, illness and empowering children to live in a better world. All shows: http://www.france24.com/en/taxonomy/emission/20132 FRANCE 24 INTERNATIONAL NEWS 24/7 http://www.france24.com
Просмотров: 56962 FRANCE 24 English
Conversation about drug pricing | Health care system | Heatlh & Medicine | Khan Academy
 
13:33
Dr. Laurence Baker talks to Sal about how drug prices are set. Created by Sal Khan. Watch the next lesson: https://www.khanacademy.org/science/health-and-medicine/health-care-system/v/health-care-costs-in-us-vs-europe?utm_source=YT&utm_medium=Desc&utm_campaign=healthandmedicine Missed the previous lesson? https://www.khanacademy.org/science/health-and-medicine/health-care-system/v/blue-cross-and-blue-shield?utm_source=YT&utm_medium=Desc&utm_campaign=healthandmedicine Health & Medicine on Khan Academy: No organ quite symbolizes love like the heart. One reason may be that your heart helps you live, by moving ~5 liters (1.3 gallons) of blood through almost 100,000 kilometers (62,000 miles) of blood vessels every single minute! It has to do this all day, everyday, without ever taking a vacation! Now that is true love. Learn about how the heart works, how blood flows through the heart, where the blood goes after it leaves the heart, and what your heart is doing when it makes the sound “Lub Dub.” About Khan Academy: Khan Academy is a nonprofit with a mission to provide a free, world-class education for anyone, anywhere. We believe learners of all ages should have unlimited access to free educational content they can master at their own pace. We use intelligent software, deep data analytics and intuitive user interfaces to help students and teachers around the world. Our resources cover preschool through early college education, including math, biology, chemistry, physics, economics, finance, history, grammar and more. We offer free personalized SAT test prep in partnership with the test developer, the College Board. Khan Academy has been translated into dozens of languages, and 100 million people use our platform worldwide every year. For more information, visit www.khanacademy.org, join us on Facebook or follow us on Twitter at @khanacademy. And remember, you can learn anything. For free. For everyone. Forever. #YouCanLearnAnything Subscribe to Khan Academy’s Health & Medicine channel: https://www.youtube.com/channel/UC1RAowgA3q8Gl7exSWJuDEw?sub_confirmation=1 Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy
Просмотров: 53712 Khan Academy
Why Prescription Drugs Cost So Much | Michael Rea | TEDxKC
 
08:15
Would you be mad if you found out you were paying as much as 2000% more than your neighbor for a prescription? Furious, Michael Rea left his job as a pharmacist eight years ago to pursue a solution to the runaway cost of prescription drugs. Dr. Michael Rea founded Rx Savings Solutions in 2008 after routinely witnessing consumers struggling to pay for their medications. He noticed quickly at that time that consumers were paying much more than they needed to, which was attributable to a lack of information available to them. He set out on his mission to arm consumers with this information and add efficiency and transparency back into the world of pharmacy. Dr. Rea has been involved with research surrounding pharmacy transparency for over 10 years. He received his Doctor of Pharmacy degree from Creighton University. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Просмотров: 23572 TEDx Talks
States move to expand generic drug price-fixing lawsuit
 
00:43
45 US attorney Generals including the district of Columbia have sought to expand a lawsuit which alleges price fixing of generic drugs to 18 companies and 15 medicines. The lawsuit chronicles an industry-wide conspiracy where companies divide the market as a way to push up prices. The multi billion dollar generic drug industry has allegedly been boosting up prices in a marketplace that was designed to deliver lower prices to customers. Connecticut Attorney General George Jepsen has said “It is our belief that price-fixing is systematic, it is pervasive, and that a culture of collusion exists in the industry.” http://feeds.reuters.com/~r/Reuters/domesticNews/~3/xHzFXLT8eEI/states-move-to-expand-generic-drug-price-fixing-lawsuit-idUSKBN1D0201 http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Просмотров: 50 Wochit News
FDA Publicly Accuses Drug Companies Of Trying To Block Generic Meds
 
00:49
According to a report by Gizmodo, the United States' Food and Drug Administration published a list of pharmaceutical companies that it accuses of impeding the development of generic drugs. The list, released on Thursday, include big names like Novartis, GlaxoSmithKline, Pfizer, and Valeant Pharmaceuticals that it accuses of putting in place obstacles that delay the development of generic medications. The list was published following President Donald Trump's statement at a White House press conference last week, where he pledged to lower prescription drug costs. He claimed that “foreign, developed nations” are getting a “free-ride by setting drug prices at unfairly low levels, leaving American patients to pay for the innovation that foreign patients enjoy.” https://gizmodo.com/fda-publicly-shames-drug-companies-that-block-generic-m-1826074736 http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Просмотров: 121 Wochit News
This Is How One Company Is Bringing Down Costs of Generic Drugs | NBC Nightly News
 
02:27
Advocates say this company's approach to insurance companies and patients’ prescriptions could be the future. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, Meet The Press, and our original series Debunker, Flashback, Nerdwatch, and Show Me. Subscribe to our channel for news stories, technology, politics, health, entertainment, science, business, and exclusive NBC investigations. Connect with NBC News Online! Visit NBCNews.Com: http://nbcnews.to/ReadNBC Find NBC News on Facebook: http://nbcnews.to/LikeNBC Follow NBC News on Twitter: http://nbcnews.to/FollowNBC Follow NBC News on Google+: http://nbcnews.to/PlusNBC Follow NBC News on Instagram: http://nbcnews.to/InstaNBC Follow NBC News on Pinterest: http://nbcnews.to/PinNBC This Is How One Company Is Bringing Down Costs of Generic Drugs | NBC Nightly News
Просмотров: 4276 NBC News
Why Are Prescription Drugs So Expensive?
 
03:45
» Subscribe to NowThis World: http://go.nowth.is/World_Subscribe The First Amendment protects free speech, but there are some exceptions. How annoying can you be before it becomes illegal? Learn More: There's Actually Free Speech Zones http://www.cnn.com/2012/09/02/politics/rnc-protest-vermin-supreme/index.html?iref=allsearch First Amendment: An Overview http://www.law.cornell.edu/wex/first_amendment "The First Amendment of the United States Constitution protects the right to freedom of religion and freedom of expression from government interference." Who is the Reasonable Person? http://www.lclark.edu/live/files/7230-lcb144art1moranpdf "As the common law's most enduring fiction, the reasonable person fulfills a great many different roles across very different bodies of law." Harassment http://definitions.uslegal.com/h/harassment/ "Harassment is governed by state laws, which vary by state, but is generally defined as a course of conduct which annoys, threatens, intimidates, alarms, or puts a person in fear of their safety." Reasonable Person http://definitions.uslegal.com/r/reasonable-prudent-man/ "Reasonable or Prudent man is a hypothetical person used as a legal standard especially to determine whether someone acted with negligence." Watch More: Is Online Trolling Illegal? https://www.youtube.com/watch?v=vdVJ2L8SabU _________________________ NowThis World is dedicated to bringing you topical explainers about the world around you. Each week we’ll be exploring current stories in international news, by examining the facts, providing historical context, and outlining the key players involved. We’ll also highlight powerful countries, ideologies, influential leaders, and ongoing global conflicts that are shaping the current landscape of the international community across the globe today. More from NowThis: » Subscribe to NowThis News: http://go.nowth.is/News_Subscribe » Like NowThis World on Facebook: https://go.nowth.is/World_Facebook » Connect with Judah: Follow @judah_robinson on Twitter – Facebook: http://go.nowth.is/LikeJudah » Connect with Versha: Follow @versharma on Twitter – Facebook: http://go.nowth.is/LikeVersha http://www.youtube.com/nowthisworld
Просмотров: 108279 NowThis World
Indian Pharma Is The Global Generic Medicine Leader - CNBC Report
 
03:15
Support this Channel at http://www.patreon.com/DLXArea1 Follow me at https://www.facebook.com/DLXAreaOne Follow me at https://twitter.com/DLXArea1 DLX Area 1 Click to Subscribe And Watch More Videos - http://goo.gl/bZDtb
Просмотров: 9857 DLX Area 1
The world's affordable pharmacy is...
 
01:36
If you've ever taken a pain killer, there's a good chance it came from India, the largest producer of generic medicines on the planet. CNNMoney takes you inside the country's biggest drug maker to see how affordable treatments are made.
Просмотров: 10447 CNN Business
The Real Deal: Generic Drug Companies Not Li
 
02:44
GLENVILLE -86% of Americans now take generic drugs and while those medications may be cheaper than the name brands, you're unknowingly giving up the ability to sue if you run into any unforeseen complications with the medication. Generic drug makers have to stick close to the name-brand formula and labeling and the Supreme Court has ruled because of those rules, they can't be held liable if something goes wrong. Debbie from Glenville has lasting effects from a drug reaction she suffered following a knee replacement, "I figured I'd come home and everything would be fine," she says but that's not what happened. She and her doctors say a generic pain medication she was taking caused renal failure and by the time she got back to the hospital, she was in serious condition. "At that point, I had 1,177 liters of urine throughout my body‚it was awful, I was so bloated I couldn't bend down to pick anything up, my legs ached, my ankles hurt, I couldn't do the therapy for my knee replacement," she says. After months of recovering, Debbie brought her case to a lawyer, "they said that you can't sue because it's a generic drug‚it took six months of my life away and they just say, "no, you can't do it, you can't sue," she says. Under federal law, generic drug makers are not allowed to change the safety warnings on their labels in response to new risks and side effects until after the name brand maker has done so. And then, the change needs to be approved by the FDA which creates a big window of time when patients may be taking the generic without updated health information. The FDA recently delayed a new rule that would require generic drug makers to independently update warnings after getting major pushback from the industry. The Generic Pharmaceutical Association argues the new rule would increase the prices of generic drugs and open up the generic drug makers to more liability. Debbie says she wouldn't mind paying a little extra for a little more piece of mind, "It was a nightmare and I don't want other people going through it," she says.
Просмотров: 128 CBS6 Albany
U S  states allege broad generic drug price fixing collusion
 
05:36
U.S. states allege broad generic drug price-fixing collusion. WASHINGTON (Reuters) - A large group of U.S. states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more drugmakers and medicines in an action that sent some company shares tumbling. The lawsuit, brought by the attorneys general of 45 states and the District of Columbia, accused 18 companies and subsidiaries and named 15 medicines. It also targeted two individual executives: Rajiv Malik, president and executive director of Mylan NV, and Satish Mehta, CEO and managing director of India’s Emcure Pharmaceuticals. Shares of Pennsylvania-based Mylan, also named as a defendant, fell more than 6 percent after the news.
Просмотров: 35 News Express
India, the pharmacy of the world
 
30:12
Farmamundi Documentary. www.farmamundi.org Access to medicines is a universal right. This documentary, with the testimonies of experts in health and legal issues, explains why India has become a world leader in the manufacture of generic drugs and follows the legal and social process of, The Gliveec Case, where Novartis took the Indian government to Court in a dispute over the granting of a patent for this drug which treats cancer. The judgment found in favour of the Indian Government earlier this year (2013). This film documents the seven year legal battle, including first hand interviews with people involved in this case, which gives the documentary a unique relevance. Finance: ACCDand City Council of Barcelona.
Просмотров: 148593 Farmamundi
States move to expand generic drug price fixing lawsuit
 
03:40
States move to expand generic drug price-fixing lawsuit. WASHINGTON (Reuters) - A large group of U.S. state attorneys general on Tuesday sought to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG’s (NOVN.S) generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd (SUN.NS). The lawsuit, brought by the attorneys general of 45 states and the District of Columbia, describes an industry-wide conspiracy in which companies divide up the market as a way to push up prices. “It is our belief that price-fixing is systematic, it is pervasive, and that a culture of collusion exists in the industry,” Connecticut Attorney General George Jepsen, who is leading the case, said at a news conference on Tuesday.
Просмотров: 3 News Express
Why are generic drugs cheaper? | By Ishan [Hindi]
 
04:39
Why are generic drugs cheaper? | By Ishan [Hindi] For developing a formula of a branded drug it requires lots of investments for research and development. In order to get that investments back they will charge more within that patent time, once the patent time is over any one can produce that medicine with same formula. So the cost of that medicine includes all costs incurred to develop the drug and benefits of the manufacturer. When it comes to Generic drug all that R&D costs will not be there so the generic drugs are cheaper. In India very few people are aware of this generic medicines, because of which people are spending more money on their medicines. That’s why recently Indian Government and The Medical Council of India (MCI) has mandated that generic names of drugs would have to be mentioned along with the brands in prescriptions to patients because there are so many medicines which are available in generics. Indian government is also encouraging the use of generic medicines by establishing some Jan Aushadhi Medical Stores in India and nowadays large number of retail generic outlets are appearing in the market and also there are some players who are selling generic medicines online like genericwala. I have switched over to buying generic medicines rather than the branded medicines and i usually order it online because it is cheaper and convenient for me. Disclaimer- Some contents are used for educational purpose under fair use. Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use. All credit for copyright materiel used in video goes to respected owner. Keep Supporting Us :- Website : https://www.ishanllb.com/ Website : http://www.eisarahi.com/ Email : help@ishanllb.com Facebook Official : https://www.facebook.com/eisarahiofficial Facebook Page : https://www.facebook.com/IshanLLB/ Other Channel : https://www.youtube.com/ishanllb Twitter : https://twitter.com/ishanllb Tags :- generic medicine information in hindi,generic medicine definition in hindi,generic medicine,generic medicine meaning in hindi,generic medicine information in india,generic medicine vs name brand,is brand name better than generic,should i buy brand name?,Why are generic drugs cheaper,जेनेरिक दवा,Generic Medicine Vs Branded,generic dawa kya hai,जेनेरिक दवा की पहचान,generic medicine itni sasti kaise,generic medicine kaise kharide,ishan health,ishanhealth,generic
Просмотров: 8234 ISHAN HEALTH
Theon Pharmaceuticals Ltd, Baddi-Best Third Party Contract Manufacturing Pharmaceutical formulations
 
10:29
Theon Pharmaceuticals Ltd Since its inception in 2005, Theon Pharmaceuticals Ltd., a WHO-GMP & ISO 9001:2008 certified company is a rapidly growing professionally managed Indian Pharmaceutical Company and is now effectively harnessing global opportunities to fortify its international presence. Theon’s State of the art modern facilities are spread over 4.5 Acres, located in lush green, excise free zone of Nalagarh in the state of Himachal Pradesh. This excise free zone is a hub of leading pharmaceutical companies of India as it provides a cost competitive edge over manufacturing units operating in other parts of India. The Company boasts of an impressive product list inclusive of niche DCGI approved formulations to meet all customer needs. It is presently a co-producer to leading pharmaceutical companies of India. • WHO - GMP and ISO 9001:2008 Certified Company • Leading Contract Manufacturing Company in the Country • State of the art Infrastructure • Dedicated and Fabricated Blocks for General, Betalactam & Cephalosporins • Automated Machines & High - Speed packing lines • Dedicated Modular Labs complying GLP norms • 100% Excise Free Zone • Exporting to ASIAN, AFRICAN & CIS Countries • NABL accredited Modular laboratories with latest sophisticated instruments Including UPLCs Theon has marked its presence globally by exporting its products to Africa, Central Asia, CIS, French West Africa, Latin America and South East Asia. We have an array of Certification. • WHO-GMP • PPB - Kenya • NDA - Uganda • FMHACA - Ethiopia • TFDA - Tanzania • MOH - Vietnam • DPM - Ivory Coast • MOH - Sri Lanka • MOH – Afghanistan • FDA- Philippines • GMP • Neutral Code (for exports) • Dietary Supplement License • Non - Conviction Certificate • ISO 9001: 2008 • NSIC - CRISIL Rating: SE 1A & BBB+ The Company has dedicated & segregated blocks for General, Penicillins (ß-lactam) & Cephalosporins dosages in the form of Tablets, Capsules, Ointments, Sachets, Injectables and Dry Syrups covering all major therapeutic segments. To carry out Real Time & Accelerated Stability Studies as per ICH guidelines, the Company maintains separate dedicated R&D laboratories and stability chambers & laboratories. For strict compliance of Good Laboratories Practices (GLP's), the Company has latest sophisticated instruments in its in-house chemical, instrumental & microbiological laboratories. Theon aims at carving a place for itself in the Indian Pharmaceutical market with specialization in new and niche molecules thereby adding value for their clients as well as customers. Theon's Global Presence Streamlining the export vision at Theon, a dedicated Export regulatory department team has been set up for complying with international audits and providing complete export documentation including COPP and dossier preparations as per CTD format. Operating in total compliance with c-GMP norms, Theon's manufacturing unit has been granted certifications by PPB - Kenya, NDA - Uganda, FMHACA - Ethiopia, TFDA - Tanzania, MOH - Vietnam, DPM - Ivory Coast, MoH - Sri Lanka, MOH - Afghanistan and several others in pipeline. Theon is currently catering to Africa, South East Asia, Central Asia, French West Africa, CIS, Latin America, Asia Pacific and many more and we endeavour to become the world class pharmaceutical manufacturer for India & neighboring countries and to assist in the development of quality products by providing superior performance with high class products in right budget. Salient Features • Built up area of 1,75,000 sq. ft with separate areas for production and stores • Quality Control, HVAC, Utilities and Administration • Separate entry and exit for man, material & service personnel for both • Designed and built as per vertical flow concept of man – material movement • c-GMP compliant latest manufacturing equipments • NABL accredited Modular laboratories with latest sophisticated instruments Including UPLCs • Highly skilled, dedicated and experienced technical staff • Automated access control system and fully equipped cameras • Immaculate environmental monitoring, calibration and validation programme Quality & innovation are the hallmark of Theon. At Theon, we strongly support Environmentalism, and keeping in mind the same, we use innovative method & technology to have highest standards of Safety, Environment and Health in our manufacturing processes. A passion for innovation…. A commitment to excellence…. A reputation for reliability…. THEON PHARMACEUTICALS LTD. For healthy lives……..
Просмотров: 96042 Naveen Thakur
Exclusive U S  states to expand generic drug price fixing suit   sources
 
02:55
Exclusive U.S. states to expand generic drug price-fixing suit - sources. WASHINGTON (Reuters) - Forty-six U.S. state attorneys general will seek to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG’s generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd, people familiar with the matter said. The original complaint, being litigated in federal court in Pennsylvania, describes an industry-wide conspiracy in which companies divide up the market as a way to push up prices. In the amended complaint, the number of generic drug manufacturers named goes from six to 18, including Endo International PLC’s unit Par Pharmaceutical, Dr. Reddy’s Laboratories, Apotex, Glenmark Generics Ltd and Lannett Company Inc, the sources said.
Просмотров: 2 News Zone
Drug companies accused of unfair tactics to stall generic meds
 
05:54
Lawmakers are considering a bill to address what President Trump called a top priority in his State of the Union speech: lowering prescription drug prices. Critics say some drug companies who want to hold onto their exclusive sales of a brand-name drug – and their profits – are playing games to stave off generic competitors, leaving patients out in the cold. Anna Werner reports. Subscribe to the "CBS This Morning" Channel HERE: http://bit.ly/1Q0v2hE Watch "CBS This Morning" HERE: http://bit.ly/1T88yAR Watch the latest installment of "Note to Self," only on "CBS This Morning," HERE: http://cbsn.ws/1Sh8XlB Follow "CBS This Morning" on Instagram HERE: http://bit.ly/1Q7NGnY Like "CBS This Morning" on Facebook HERE: http://on.fb.me/1LhtdvI Follow "CBS This Morning" on Twitter HERE: http://bit.ly/1Xj5W3p Follow "CBS This Morning" on Google+ HERE: http://bit.ly/1SIM4I8 Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8 Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B Delivered by Norah O’Donnell and Gayle King, "CBS This Morning" offers a thoughtful, substantive and insightful source of news and information to a daily audience of 3 million viewers. The Emmy Award-winning broadcast presents a mix of daily news, coverage of developing stories of national and global significance, and interviews with leading figures in politics, business and entertainment. Check local listings for "CBS This Morning" broadcast times.
Просмотров: 1106 CBS This Morning
Mobile App | For | Generic Medicine | List
 
00:51
For more info log on to www.24taas.com Like us on https://www.facebook.com/Zee24Taas Follow us on https://twitter.com/zee24taasnews
Просмотров: 4573 ZEE 24 TAAS
Generic Drug Group Goes Against Maryland Price-Gouging Law
 
00:50
The main U.S. trade group for generic pharmaceutical companies filed a lawsuit on Thursday seeking to block a recently adopted Maryland law that lets the state attorney general sue generic drugmakers that sharply raise prices. The Association for Accessible Medicines filed the lawsuit in federal court in Baltimore to seek an injunction that would block state officials, including Maryland Attorney General Brian Frosh, from enforcing the law. Chip Davis, the group's chief executive, said in a statement, "If this new law goes into effect, it will harm patients and our communities by reducing choice and limiting access to essential medicines that people need." http://feeds.reuters.com/~r/Reuters/domesticNews/~3/ceFSDQ-DkN4/us-maryland-pharmaceuticals-idUSKBN19R2VV http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Просмотров: 60 Wochit News
"Fire in the Blood": Millions Die in Africa After Big Pharma Blocks Imports of Generic AIDS Drugs
 
12:03
DemocracyNow.org - The new documentary, "Fire in the Blood," examines how millions have died from AIDS because big pharmaceutical companies and the United States have refused to allow developing nations to import life-saving generic drugs. The problem continues today as the World Trade Organization continues to block the importation of generic drugs in many countries because of a trade deal known as the Trips Agreement. We're joined by the film's director, Dylan Mohan Gray, and Ugandan AIDS doctor Peter Mugyenyi, who was arrested for trying to import generic drugs, and is
Просмотров: 22185 Democracy Now!
States move to expand generic drug price fixing lawsuit
 
03:40
States move to expand generic drug price-fixing lawsuit. WASHINGTON (Reuters) - A large group of U.S. state attorneys general on Tuesday sought to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG’s (NOVN.S) generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd (SUN.NS). The lawsuit, brought by the attorneys general of 45 states and the District of Columbia, describes an industry-wide conspiracy in which companies divide up the market as a way to push up prices. “It is our belief that price-fixing is systematic, it is pervasive, and that a culture of collusion exists in the industry,” Connecticut Attorney General George Jepsen, who is leading the case, said at a news conference on Tuesday.
Просмотров: 3 News Zone
Marketing to Doctors: Last Week Tonight with John Oliver (HBO)
 
17:13
Pharmaceutical companies spend billions of dollars marketing drugs to doctors. We have a few issues with that. Connect with Last Week Tonight online... Subscribe to the Last Week Tonight YouTube channel for more almost news as it almost happens: www.youtube.com/user/LastWeekTonight Find Last Week Tonight on Facebook like your mom would: http://Facebook.com/LastWeekTonight Follow us on Twitter for news about jokes and jokes about news: http://Twitter.com/LastWeekTonight Visit our official site for all that other stuff at once: http://www.hbo.com/lastweektonight Connect with Last Week Tonight online... Subscribe to the Last Week Tonight YouTube channel for more almost news as it almost happens: www.youtube.com/user/LastWeekTonight Find Last Week Tonight on Facebook like your mom would: http://Facebook.com/LastWeekTonight Follow us on Twitter for news about jokes and jokes about news: http://Twitter.com/LastWeekTonight Visit our official site for all that other stuff at once: http://www.hbo.com/lastweektonight
Просмотров: 10274683 LastWeekTonight
Brand vs. Generic Drugs.mov
 
05:11
Rxvista.com facilitates to create awareness among users to cut the Healthcare Drug costs, generic versus Brand name drugs, cut cost of healthcare, cheap medicine, best medicine, save on healthcare
Просмотров: 10523 rxvista
U.S. States Accuse Drug Industry Of Collusion
 
00:58
According to Reuters on Tuesday a large group of U.S. states are calling out key players in the generic drug industry accusing them of a broad price-fixing conspiracy. The move brings broadens an earlier lawsuit moving to add many more drugmakers and medicines an action that sent some company shares tumbling. 45 attorney generals, along with the District Of Columbia raised the allegations against 18 companies and subsidiaries and named 15 medicines. Two individual executives have also been included in the allegations, Rajiv Malik, president and executive director of Mylan NV, and Satish Mehta, CEO and managing director of India’s Emcure Pharmaceuticals. http://feeds.reuters.com/~r/Reuters/domesticNews/~3/EwRZUi6yAjU/u-s-states-allege-broad-generic-drug-price-fixing-collusion-idUSKBN1D0201 http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Просмотров: 143 Wochit News
Dangerous Drugs News: Generic Drugs May Be Liable For Injuries In the Near Future
 
01:05
Visit http://www.rotlaw.com/lawsuits/dangerous-drugs/ for more information on dangerous drugs. The Supreme Court of the United States is hearing arguments this week in a case that could give patients injured by generic medications the right to sue. Currently, only original manufacturers can be held liable for harms caused by prescription medications. Karen Barrett of New Hampshire sued Mutual Pharmaceuticals of Philadelphia after she went blind and her skin began to fall off following her use of the generic drug Sulindac, which the company manufactures. A jury awarded her 21 million dollars. An appeals court upheld the verdict and the award. If the Supreme Court upholds the ruling of the lower courts, it would open the door for claims against generic drug manufacturers, who are by federal law required to reproduce the original design and labeling of a brand-name drug. The Rottenstein Law Group encourages patients to visit http://www.rotlaw.com/lawsuits/dangerous-drugs/ for more updates on the Supreme Court trial and for more information on dangerous drugs. Rottenstein Law Group, LLP 321 W 44th St # 804 New York, NY 10036 (212) 933-9500 http://www.youtube.com/watch?v=HC7djvoyWaA
Просмотров: 525 RotlawNewsDesk
Supreme Court Rules in Favor of Generic  Drug Preemption
 
04:22
The United States Supreme Court held in Pliva, Inc. v. Mensing that federal drug labeling laws directly conflict with, and therefore impliedly preempt, state law failure-to-warn claims against generic drug manufacturers. Mensing is the latest in a series of federal preemption cases involving the pharmaceutical and medical device industry
Просмотров: 284 tcdevoto
20 States Accuse Generic Drug Companies of Price Fixing Free Audiobook
 
00:33
Get a full audiobook of your choice, legally and zero cost : http://cran.space/11/b01n6b7y0t Format: Unabridged Written by: Katie Thomas Release date: 12/16/2016 Duration: 5 mins Language: English Genre: newspapers & magazines, news & culture Summary: "20 States Accuse Generic Drug Companies of Price Fixing" is from the December 15, 2016 Business section of The New York Times. It was written by Katie Thomas and narrated by Kristi Burns. 2016 The New York Times News Service Division of The New York Times Company (P)2016 Audible, Inc. Contact me for any question: reqabk@gmail.com
Просмотров: 0 Laura Washington
U S  states move to expand generic drug price fixing lawsuit
 
03:41
U.S. states move to expand generic drug price-fixing lawsuit. WASHINGTON (Reuters) - A large group of U.S. state attorneys general on Tuesday sought to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG’s (NOVN.S) generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd (SUN.NS). The lawsuit, brought by the attorneys general of 45 states and the District of Columbia, describes an industry-wide conspiracy in which companies divide up the market as a way to push up prices. “It is our belief that price-fixing is systematic, it is pervasive, and that a culture of collusion exists in the industry,” Connecticut Attorney General George Jepsen, who is leading the case, said at a news conference on Tuesday.
Просмотров: 1 News Zone
Price fix? Drug companies drastically raising generic drug prices
 
03:55
A federal investigation into price fixing by generic drug companies shows no sign of slowing down and several warrants have been served to corporate offices.
Просмотров: 121 WSB-TV
The FDA and the Pharmaceutical Industry
 
01:33:53
Carpenter, author of Reputation and Power:Organizational Image and Pharmaceutical Regulation at the FDA will join us to discuss the FDA and the pharmaceutical industry. The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Carpenter traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Sponsored by the USC Bedrosian Center as part of it's on-going Governance Salons. Daniel Carpenter is Allie S. Freed Professor of Government and Director of the Center for American Political Studies in the Faculty of Arts and Sciences at Harvard University. For the 2011-2012 academic year, he is a Walter Channing Cabot Faculty Fellow at Harvard, and a visiting researcher at the Institut d'Études Politiques at the Université de Strasbourg in France. He graduated from Georgetown University in 1989 with distinction in Honors Government and received his doctorate in political science from the University of Chicago in 1996. He taught previously at Princeton University (1995-1998) and the University of Michigan (1998-2002). He joined the Harvard University faculty in 2002. Dr. Carpenter mixes theoretical, historical, statistical and mathematical analyses to examine the development of political institutions, particularly in the United States. He focuses upon public bureaucracies and government regulation, particularly regulation of health and financial products. His dissertation received the 1998 Harold D. Lasswell Award from the American Political Science Association and as a book - The Forging of Bureaucratic Autonomy: Reputations, Networks and Policy Innovation in Executive Agencies, 1862-1928 (Princeton: Princeton University Press, 2001) - was awarded the APSA's Gladys Kammerer Prize as well as the Charles Levine Prize of the International Political Science Association. His recently published book on pharmaceutical regulation in the United States is entitled Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton: Princeton University Press, 2010), and has received the 2011 Allan Sharlin Memorial Award from the Social Science History Association. Professor Carpenter has held fellowships from the John Simon Guggenheim Foundation, the Radcliffe Institute for Advanced Study, the Center for Advanced Study in the Behavioral Sciences, the Brookings Institution and the Santa Fe Institute. He has received grants from the National Endowment for the Humanities, the National Science Foundation, the Robert Wood Johnson Foundation (Scholars in Health Policy 1998-2000, Investigator Award in Health Policy Research 2004-2007), the Alfred Sloan Foundation, the Russell Sage Foundation and the Safra Center for Ethics. In the past few years, Professor Carpenter is the winner of both the 2011 Herbert Simon Award of the Midwest Political Science Association for a scholar "who has made a significant career contribution to the scientific study of bureaucracy", as well as the 2011 David Collier Award of the American Political Science Association for career contributions to qualitative and multi-method research. In addition to his ongoing teaching and scholarship on the political economy of government regulation and health, Professor Carpenter has recently launched a long-term project on petitioning in North American political development, examining comparisons and connections to petitioning histories in Europe and India. He hopes to draw upon the millions of petitions in local, state and federal archives to create an educational, genealogical and scholarly resource for citizens, students and scholars.
Просмотров: 39454 USC Price
Inside the Indian Generic Drug Manufacturer Cipla
 
02:53
India produces over 30% of the world's entire supply of generic drugs. Cipla is one of India's largest drug manufacturers. It supplies antiretroviral drugs to about one third of AIDS patients under treatment in Africa. C&EN Senior Correspondent Jean-François Tremblay went inside Cipla's advanced pharmaceutical ingredient manufacturing plant to learn more about the stringent regulations it must follow. India's future as the world's drugstore is a controversial topic. Other drugmakers have been heavily fined, or had products recalled or banned, because of problems at plants. And India is under pressure to make its patent system more like those in western nations. But India has found a market for low-cost drugs and that market isn't about to disappear. More at http://cenm.ag/cpla Like C&EN? Want more chemistry video goodness? Subscribe to our YouTube channel: https://www.youtube.com/user/CENonline Subscribe to C&EN to watch science videos with a focus on chemistry, and to hear from the researchers behind it all. -- Looking for C&EN elsewhere on the internet? Homepage: http://cen.acs.org Facebook: http://www.facebook.com/CENews Twitter: http://www.twitter.com/cenmag Tumblr: http://cenwatchglass.tumblr.com
Просмотров: 78258 CEN Online
Made In India-Pharmaceutical Industry-2015
 
09:19
The Pharmaceutical industry in India is the world's third-largest in terms of volume. According to Department of Pharmaceuticals the total turnover of India's pharmaceuticals industry between 2008 and 2009 was US$21.04 billion. India is one of the fastest-growing pharmaceutical markets in the world and has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce gives the industry a definite competitive advantage. India is today one of the top emerging markets in the global pharmaceutical scene. The sector is highly knowledge based and its steady growth is positively affecting the Indian economy. The organized nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. In 2013, there were 4,655 pharmaceutical manufacturing plants in all of India, employing over 345 thousand people The government of India started to encourage the growth of drug manufacturing by Indian companies in the early 1960s, and with the Patents Act in 1970. However, economic liberalization in 1990s enabled the industry to flourish. Indian companies carved a niiche in both the Indian and world markets with their expertise in engineering new processes for manufacturing drugs at low costs. Although some of the larger companies have taken small steps towards drug research and innovation, the industry as a whole has been following this business model until the present. The Indian pharmaceutical industry was estimated to be worth US$ 23 billion in 2 thousand 10 and is expected to touch US$ 55 billion by 2016. Globally, India ranks third in terms of volume of production and fourteenth largest by value. The domestic market is likely to grow from US$ 13 billion in 2010 to US$ 25 billion by 2017. The domestic pharma sector is witnessing strong growth due to higher penetration in tier-2 and tier-3 cities and greater focus on the largely- untapped rural market. The major factors responsible for this growth are increasing sales of generic medicines, continued growth in chronic therapies and greater penetration in rural markets. India exports to more than 200 countries; its share of exports is expected to grow incrementally. Pharmaceutical exports grew from US$ 8.6 billion in 2008 to US$ 14.5 billion in 2012, at a rate of 13.8 per cent. The US is India’s largest importer. The exports to the US grew at a rate of around 24 per cent between 2006 and 2010. The export of bulk drugs continue to grow to regulated markets and is supported by India’s existing foothold in semi-regulated market. India currently exports drug intermediates, Active Pharmaceutical Ingredients, Finished Dosage Formulations Bio-Pharmaceuticals, and Clinical Services across the globe. The exports of pharmaceuticals from India grew to US$ 14.6 billion in 2012from US$ 6.23 billion in 2006, registering a compound annual growth rate of around 15.2 per cent. India, with almost 200, US FDA drug manufacturing facilities, is the biggest foreign supplier of medicines to the United States . Exports to the US rose nearly 32 per cent last year to US$ 4.23 billion. India accounts for nearly 40 per cent of generic drugs and over-the-counter products and 10 per cent of finished dosages used in the US. Generic drugs have a dominant position in the rapidly expanding Indian drug industry. India's exports of generic drugs have been growing at a rate of 24 per cent over the past four years. In the period 2002 to 2012, the country’s healthcare sector grew 3 times in size, touching US$ 70 billion from US$ 23 billion. The Top 10 Publicly Listed pharma companies in India by Market Capitalization as of 2015 are Sun Pharmaceutical, Lupin Pharmaceuticals, Dr. Reddy's Labs, Cipla, Aurobindo Pharmaceutical, Cadila Healthcare, Glenmark Pharmaceuticals, Divis Labs and Torrent Pharmaceuticals. The Indian pharma industry is on a good growth path and is likely to be in the top 10 global markets in value terms by 2 thousand 20, according to the Price water cooper report. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market, the report highlighted. The small and medium enterprises are expected to play a significant role in the growth story of the country's pharma sector as they contribute 35–40 per cent to the industry in terms of production
Просмотров: 34844 KoSh Films
Big Pharma Profits Driven By Patent Abuse (with Prof. Brook K Baker)
 
15:54
The importance of the Indian Supreme Court's decision on generic drugs, why the bar is lower for generic drug production in the United States,why Pharma companies drive inefficiency and threaten global health, why pharma companies are primarily marketing firms , why medicine is a "Global Public Good" and why "free trade agreements" are simply a giveaway for corporations... This clip from the Majority Report, live M-F at 12 noon EST and via daily podcast at http://Majority.FM Subscribe to us on YouTube: http://youtube.com/user/SamSeder
Просмотров: 1316 The Majority Report w/ Sam Seder
India rejects Novartis drug patent
 
01:19
http://www.euronews.com/ India's Supreme Court has rejected a request by Swiss drug-maker Novartis to patent an updated version of its cancer drug Glivec. Glivec costs around 2,000 euros per month whereas the domestically produced generic equivalent costs around 140 euros. The judgement is supported by healthcare activists who want the government to make medicines cheaper. Neena Manghaney from Médecins Sans Frontières (Doctors Without Borders) said: "It's hugely significant because eight million people with HIV are on treatment from India more than 80 percent of these people get these drugs from India. In the area of HIV, this decision is path breaking. Number 2 is this: By protecting generic competition and abusive practices of pharma companies like Novartis, I think the Supreme Court has safeguarded the rights of patients across the developing world." The ruling is a blow to Western firms who are increasingly focusing on India to drive sales. Pratibha Singh, an advocate for Indian drug-makers, said there is no ambiguity in the Supreme Court's decision: "One implication is clear that the Indian provision, Section 3d has been completely upheld ,No1?No2, patent would be granted only for genuine inventions and repetitive patenting will not be allowed." This case is a benchmark for several intellectual property disputes in India, where patent drugs are unaffordable for most of its 1.2 billion people, 40 percent of whom live on less than a euro per day. Find us on: Youtube http://bit.ly/zr3upY Facebook http://www.facebook.com/euronews.fans Twitter http://twitter.com/euronews
Просмотров: 4345 euronews (in English)
Lawsuit Accuses Drug Makers Of Fixing Generic Drug Prices
 
00:30
More than a dozen companies and 18 medicines are named in the price-fixing lawsuit.
Просмотров: 91 CBS Miami
U S  states move to expand generic drug price fixing lawsuit
 
03:41
U.S. states move to expand generic drug price-fixing lawsuit. WASHINGTON (Reuters) - A large group of U.S. state attorneys general on Tuesday sought to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG’s (NOVN.S) generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd (SUN.NS). The lawsuit, brought by the attorneys general of 45 states and the District of Columbia, describes an industry-wide conspiracy in which companies divide up the market as a way to push up prices. “It is our belief that price-fixing is systematic, it is pervasive, and that a culture of collusion exists in the industry,” Connecticut Attorney General George Jepsen, who is leading the case, said at a news conference on Tuesday.
Просмотров: 0 News Zone
United States Generic Drugs Market to be USD 210 Billion by 2024
 
01:13
For more Info: https://www.renub.com/united-states-generic-drugs-market-nd.php As per Renub Research analysis United States Generic Drugs Market is anticipated to be more than USD 210 Billion by the year 2024. It has approximately 80% share of total dispensing prescriptions. Now most of the physicians and hospitals like prescribe generic drugs as compared to branded drugs. What is a Generic Drug? It is a Pharmaceutical drug that has the same chemical composition as patented drug. It has the same Active Pharmaceutical Ingredient (API) as original, but may have different manufacturing process, excipients, color, taste and packaging. It is only allowed when the patent(s) of on original drug is expired. Request a free sample copy of the report: https://www.renub.com/contactus.php Generic Drugs Market in United States In 2007, the Food and Drug Administration (FDA) launched the Generic Initiative for Value and Efficiency (GIVE) to increase the number and a variety of generic products by modernizing and streamlining approval process for generic drugs in US. For making a generic drug, pharmaceutical companies are required to file an Abbreviated New Drug Application with FDA. Why Generic Drugs are more affordable than Branded Drugs? A branded drug has to go through many phases before coming into the market; initial phase is drug discovery, target identification and validation then Primary Screening, Secondary Screening, Lead Optimization, Pre-Clinical Animal Studies and various other tests. As new drug development is a complex process and involves various R & D of chemicals, but clinical trials and regulatory processes are also required to be approved for human use of drugs. How Drugs Development Process Works? According to some studies only 5 out of 5000 preclinical drugs are tested on the human for medical use out of those 5 drugs only 1 is approved by FDA. There are various stages involved in drug development. Drug Discovery and Target Validation: In this stage drug development company chooses a molecule, such as a protein or gene and test it with a drug. After testing multiple drugs only a few are selected for next stage. Preclinical Testing: It is divided into subcomponents: in vitro and in vivo testing. In vitro testing examines drug molecules interactions in test tubes in the lab setting. In vivo testing involves test is being done on animal models and other living cell cultures. These tests may take several years before going to next stage. Investigational New Drug Application Filing: At this stage an application is submitted to FDA before beginning human clinical trials. At this point FDA will scrutinize the outcomes of preclinical testing, side effects and other safety measures for an experimental drug. When IND got approved by FDA then it can move onto human trials. After IND approval a patented drugs' 20 year exclusivity period begins. Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/united-states-off-label-drugs-market-and-forecast-51-p.php Phase 1 Clinical Studies: At this stage testing involves a small group of healthy people from a dozen to a few in numbers and safety is taken as a primary concern. Now all the side effect of drug, how a drug is absorbed & elimination from the body is tested. Phase 2 Clinical Studies: After getting positive outcomes from Phase1, Phase 2 begins in this phase the number of patients grows from a few dozen to 100 or more patients who are suffering from disease. Safety is also a big concern at this point and short term side effects are also monitored closely. Phase 3 Clinical Studies: At this stage the number of patients for drug testing grow from a few hundred to thousands. It is the longest and costliest of all components of development process. New Drug Application Filing: At this point application is filed to FDA, with all the research and safety data of initial stages having tens of thousands to 100,000 or more pages. After getting affirmation from FDA, Prescription Drug User Fee Act (PDUFA) date is set 10 months. PDUFA Date and Decision: FDA will wait for PDUFA date for its decision. FDA has 3 choices: it can approve a drug, it can deny a drug or it can request additional information by sending a Complete Response Later (CRL). If a drug is approved by FDA, now it becomes immediately available for commercial production. Phase 4 Clinical Studies: After 8 steps an approved drug can used for medical purpose, but it doesn't mean it is not under scrutiny of FDA, FDA can request long-term safety measures, side effect and adverse effect of drug.
Просмотров: 9 Renub Research
McKinsey: Africa pharma sector worth $65 billion by 2020
 
05:55
Africa's pharmaceutical industry is among the fastest-growing industries globally. It's expanded from $4.7 billion to $20.8 billion in a period of ten years. Mckinsey predicts the market will be worth up to $65 billion by 2020 -- but Africa needs to make a bigger contribution to this process. Analysts estimate that by 2017, the need for prescription medicine, generics, over-the-counter drugs and medical devices on the continent will grow by up to 11%. Catalyst Principal Partners, a leading East African focused private equity firm, has acquired a controlling stake in Zenufa Laboratories in Tanzania. Though the healthcare sector in the country is dominated by foreign imports, the company chose to invest in an established local firm. Zenufa is the second largest local pharmaceutical generics manufacturer in Tanzania.
Просмотров: 2042 CGTN Africa
Pharmaceutical Manufacturing in Malaysia
 
06:26
ROYCE Pharma Manufacturing Sdn Bhd (ROYCE Pharma) is a dynamic, vibrant, progressive pharmaceutical manufacturing company. It is fully equipped with state of the art facilities for formulation in Research & Development, manufacturing of both pilot and commercial batches, Warehousing & Distribution and Sales & Marketing of Pharmaceutical Products. ROYCE manufactures generic pharmaceutical products cost-effectively, to compete with both domestic manufacturers and imports. Generic pharmaceutical products are bio equivalent and therapeutic equivalent alternatives to branded drugs that have lost market exclusivity of patent protection. Since the commencement of commercial production, ROYCE has been producing and marketing over 100 products that cover the various major lines of drugs
Просмотров: 79 aatworld vedio
Generic Drug Stocks
 
04:39
http://profitableinvestingtips.com/investing-tips/generic-drug-stocks Generic Drug Stocks By www.ProfitableInvestingTips.com. Pharmaceutical companies that make generic drugs were once a niche market. Today generic drug companies are set to bypass the makers of brand name drugs in sales value and volume according to About Money. Just a few years ago generic drug makers owned just a small slice of the pharmaceutical drug market. Today generics are a formidable segment of the industry and are on track to surpass branded drugs in sales value as well as sales volume within a few years, according to industry analysts. In the United States - where about 80 percent of all scripts written are for generics -- and traditional markets in Europe, multinational branded firms feeling losses from the patent cliff, health care reform legislation and austerity, are forming partnerships with their generic competitors to tap the expansion in generic sales. The top worldwide generic drug stocks and their 2012 generic drug sales are the following: • Teva, $10.4 billion • Mylan, $5.8 billion • Hospira, $4.1 billion • Sanofi, €1.8 billion • Ranbaxy Laboratories Ltd., $2.3 billion • Aspen Pharmacare Holding Ltd., 15.3 billion rand • STADA Arzneimittel AG, €1.2 billion Teva is the clear leader and Teva wants to take over Mylan. Teva to Acquire Mylan The New York Times reports that two generic drug stocks may become one as Teva seeks to acquire its rival Mylan. The deal making reached a fevered pitch on Tuesday when Teva, an Israeli maker of generic drugs, made an unsolicited $40 billion offer for Mylan, a rival based in the Netherlands. Getting bigger gives you better pricing and better leverage and also gets you into more markets.” This is especially true for generic drug makers, which rely less on research and development and more on maximizing profits from increasingly large global operations. Teva makes the case that by taking over Mylan they will add to their lead among generic drug stocks and increase annual revenue to around $30 billion as well as realize about $2 billion in cost savings. What Are Generic Drug Stocks? The Food and Drug Administration defines generic drugs. A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to a brand/reference listed drug product in dosage form, strength, quality and performance characteristics, and intended use." And generic drugs are cheaper than brand name drugs. This is because generic drug companies do not have the same research and development costs that big pharmaceutical companies have. They simply wait for the patent to expire on new blockbuster medications and make an identical medication for much less money. There are all sorts of new miracle drugs in the world and they are simply too expensive for the vast majority of people who take them. Generic drug stocks prosper because they provide necessary medications for the likes of the aging of populations in North America, Europe and Japan which increase their prescribed drug consumption every year. Should You Invest in Generic Drug Stocks? No matter how attractive generic drug stocks may seem fundamental stock analysis will tell you if a stock or a pending deal has good intrinsic value or not. There are pitfalls that Teva could fall into and not succeed in acquiring Mylan. These are antitrust concerns and a Mylan poison pill. If you are interested in generic drug stocks do your homework first. http://youtu.be/N113JpVAxok
Просмотров: 257 InvestingTip
Sun Pharma CNF Kolkata
 
06:03
The Video gives you a walk in feel of how a Pharmaceutical CNF operates. HiTech Dentics is the CNF of Sun Pharma for West Bengal and various neighboring states. With the Head office in Howrah, West Bengal, Hitech dentics has established a benchmark as to how a CNF should ideally operate. Do watch the video, and tell us how you feel.. Contact: 9831078481 HiTech Dentics Pvt Ltd
Просмотров: 10334 ashok butta
Affordable Access to Generic Drugs Is Safe - For Now
 
01:27
On April 1, 2013, a landmark ruling by India's Supreme Court ensured continued access to affordable HIV medication for the millions affected by this disease, including the 220,000 patients that Doctors Without Borders/Médecins Sans Frontières (MSF) treats with generic HIV/AIDS medication. This access has been under threat for the past seven years by pharmaceutical company Novartis, which challenged a section of India's Patents Act that prevented the practice of "evergreening," or extending the patent of an existing medicine by modifying it slightly. By extending patents, pharmaceutical companies prevent the manufacture of generic drugs. The ruling by India's Supreme Court is a victory for those fighting for access to affordable medicine -- at least, for the time being.
Просмотров: 1232 Doctors Without Borders / MSF-USA
Highlights from Craig Burton on the Newly Released 2018 Generic Drug Access & Savings Report
 
01:41
AAM's VP Policy Craig Burton shares the release of the 2018 Generic Drug Access & Savings in the U.S. report, which focused this year on savings from patient utilization of generic drugs. The report highlights 3 important findings: 1) 9 out of every 10 prescriptions in the U.S. are generic drugs 2) 93% of generic prescriptions are filled for less than $20 3) The average copay for patients using generic drugs is $6.06 (compared to a brand-name drug average of over $40) Competition from generic drugs is a key component of containing drug costs. Craig also shares that this access and savings is in jeopardy as a result of imbalances in the marketplace, anti-competitive behaviors by some brand-name drug manufacturers and policy miscues by federal and state policymakers centered around the lack of understanding around the generic drug market. To learn more, visit: http://www.RxAccessReport.us
Просмотров: 48 Association for Accessible Medicines
Indian Supreme Court Protects Low Cost Life Saving Drugs (with Prof. Brook K. Baker)
 
10:09
The importance of the Indian Supreme Court's decision on generic drugs, why the bar is lower for generic drug production in the United States,why Pharma companies drive inefficiency and threaten global health, why pharma companies are primarily marketing firms , why medicine is a "Global Public Good" and why "free trade agreements" are simply a giveaway for corporations... This clip from the Majority Report, live M-F at 12 noon EST and via daily podcast at http://Majority.FM Subscribe to us on YouTube: http://youtube.com/user/SamSeder
Просмотров: 2746 The Majority Report w/ Sam Seder
Bentley Hawley - Pharmaceuticals | Biotechnology - Texas State Business Network
 
01:06
Bentley Hawley is the President and Chief Pharmacist at Ben-Ray Inc, one of Odessa's finest pharmaceutical companies offering premier name brand and generic products along with authoritative medical advice.
Просмотров: 43 TexasSBN
Big Pharma’s Price Gouging Days Could Soon Be Over
 
00:55
Via America's Lawyer: Mike Papantonio talks about the fight between attorney generals nationwide and pharmaceutical companies price fixing of generic drugs. Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Order Mike Papantonio's new novel Law and Disorder today: https://www.amazon.com/Law-Disorder-Mike-Papantonio/dp/1590793676 Follow more of our stories at http://www.TROFIRE.com Subscribe to our podcast: http://www.ROFPodcast.com Support Ring of Fire by subscribing to our YouTube channel: https://www.youtube.com/user/golefttv?sub_confirmation=1 Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Instagram: https://www.instagram.com/ringoffirenetwork/
Просмотров: 3088 The Ring of Fire
How Trump plans to lower drug prices in US
 
08:22
Dr. Janette Nesheiwat and Heritage Foundation senior fellow Ed Haislmaier discuss why European countries are paying less for prescription drugs than the United States and how the Trump administration plans to combat this problem.
Просмотров: 5061 Fox Business
Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical companies
 
02:25
Browse the Report @ http://www.reportsnreports.com/reports/275193-innovative-drug-delivery-systems-opportunities-for-generic-specialty-pharmaceutical-companies.html A Report on "Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical companies" added to Reportandreport's huge Database of Accurate and Informative Industry Analysis. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com.
Просмотров: 190 victoria ernest
A Mother's Plea to CEO After EpiPen Price Jumped 400%
 
09:31
http://democracynow.org - The pharmaceutical giant Mylan has announced it will launch a cheaper generic version of its life-saving allergy shot EpiPen amid public outcry over its alleged price gouging. However, consumer advocates say the cost of the generic drug is still prohibitively expensive and triple the price of what EpiPen cost in 2007 when Mylan acquired the product. The company increased the price of its allergy injector by some 400 percent in less than a decade, sparking a national conversation about the monopoly power of pharmaceutical companies. Across the United States, millions of children and adults rely on the pocket-sized EpiPen to counteract fatal allergic reactions from common occurrences such bee stings and peanut consumption. For more, we speak with Ashley Alteman, who runs a website called SmashleyAshley.com, where she has just posted an open letter to Mylan CEO Heather Bresch. Democracy Now! is an independent global news hour that airs weekdays on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 8-9AM ET: http://democracynow.org Please consider supporting independent media by making a donation to Democracy Now! today: http://democracynow.org/donate FOLLOW DEMOCRACY NOW! ONLINE: Facebook: http://facebook.com/democracynow Twitter: https://twitter.com/democracynow YouTube: http://youtube.com/democracynow SoundCloud: http://soundcloud.com/democracynow Daily Email: http://democracynow.org/subscribe Google+: https://plus.google.com/+DemocracyNow Instagram: http://instagram.com/democracynow Tumblr: http://democracynow.tumblr.com Pinterest: http://pinterest.com/democracynow iTunes: https://itunes.apple.com/podcast/democracy-now!-audio/id73802554 TuneIn: http://tunein.com/radio/Democracy-Now-p90/ Stitcher Radio: http://www.stitcher.com/podcast/democracy-now
Просмотров: 5880 Democracy Now!
Suing Manufacturers of Generic Drugs - The Truth about Bartlett Vs. Mutual
 
04:58
A PowerPoint presentation explaining the recent news story about the Bartlett vs. Mutual court case and how I believe that the media is misinforming people about what the verdict means for our country and for those who plan on taking legal action for injuries caused by taking a generic prescription drug. Please share this with anyone you know who has been injured by generic drug use and is in a similar situation to Karen Bartlett, especially if they plan on suing their medication's manufacturer in the near future!
Просмотров: 257 DGPeoplesAdvocate